Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial [1], which has recruited and dosed its target 286 th adult patient The ACTION3 Phase 3 trial explores the efficacy and ...

Precision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver Meeting® Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts ...

CINCINNATI--(BUSINESS WIRE)--Edge Energy, a leader in innovative energy solutions, today announced a collaborative next-generation solution with Lincoln Electric that is designed to bring, fast ...

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025 Positive, early results ...

We’re familiar with single-phase AC at the outlet, but multiphase AC offers advantages and is necessary for higher-power installations. For most engineering designs, the circuit’s DC operating power ...

Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...

Please provide your email address to receive an email when new articles are posted on . Patients who received 4D-150 3E10 vg/eye experienced an 8.4 letter increase in BCVA. 4DMT is progressing to a ...

ICONIC-LEAD achieved its co-primary endpoints of PASI-90 and IGA of 0 or 1 at week 16; 74% of patients achieved clear or almost clear skin (IGA 0/1) at week 24 ICONIC-TOTAL achieved its primary ...